Leigh Precopio

fda alert
fda alert
06/07/2023
Leigh Precopio
The US FDA recently approved a novel treatment for moderate to severe vasomotor symptoms that are caused by menopause.
06/07/2023
fda alert
fda alert
10/19/2023
Leigh Precopio
The FDA approved the use of quizartinib for certain patient populations with acute myeloid leukemia in July 2023.
10/19/2023
research summary
research summary
06/21/2023
Leigh Precopio
Researchers examined the efficacy and safety of a humanized monoclonal antibody for the treatment of active psoriatic arthritis in some patient populations.
06/21/2023
research summary
research summary
10/30/2023
Leigh Precopio
Researchers examined trends and patterns of emergency department visits and hospitalizations for suicidality among pediatric patients.
10/30/2023
research summary
research summary
06/13/2023
Leigh Precopio
Many pediatric patients who are recommended to receive two doses of the influenza vaccine do not receive both doses, despite vaccinations being associated with a significant decrease in the risk of...
06/13/2023
research summary
research summary
10/26/2023
Leigh Precopio
Despite being approved for use, consensus among the real-world data on the use of IL-23 inhibitors in psoriatic disease has been lacking; therefore, researchers recently examined the drug survival and...
10/26/2023
fda alert
fda alert
07/28/2023
Leigh Precopio
The FDA has examined the results of a recent confirmatory trial to verify the clinical benefit of an amyloid beta-directed antibody for the treatment of Alzheimer disease.
07/28/2023
research summary
research summary
11/30/2023
Leigh Precopio
Individuals with acute myeloid leukemia often have low levels of vitamin C and vitamin D at the time of diagnosis. Researchers examined how supplementation of these vitamins during treatment impacted...
11/30/2023
research summary
research summary
08/28/2023
Leigh Precopio
In a recent study, researchers examined the effectiveness of text messaging to support the use of pre-exposure prophylaxis use in certain patient populations who are at high-risk of HIV infection.
08/28/2023
conference coverage
conference coverage
01/31/2024
Leigh Precopio
Individuals with HIV are at higher risk of severe disease from COVID-19. In a recent study, researchers aimed to examine the factors that influence COVID-19 vaccine uptake in this patient population.
01/31/2024